About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Altace

Company: Baylor Research Institute
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: 18 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

18 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Trial details

Recruiting NCT NCT02735707

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Not yet reported UMC Utrecht 20000 participants Est. completion 2028-02 408 sites

Other conditions: Community-acquired Pneumonia, Influenza, COVID-19
View official trial listing →
Recruiting NCT NCT02817360

NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

Not yet reported Martin Huelsmann 2400 participants Est. completion 2026-12 21 sites

Type 2 diabetes Other conditions: Heart Diseases
View official trial listing →
Recruiting NCT NCT02842424

Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis

Not yet reported University of Nebraska 70 participants Est. completion 2026-06 1 site Stand-alone

Other conditions: Peripheral Arterial Disease
View official trial listing →
Recruiting NCT NCT03440177

Bariatric Surgery and Pharmacokinetics of Ramipril

Norwegian University of Science and Technology 12 participants Est. completion 2026-12 1 site

Other conditions: Obesity, Morbid
View official trial listing →
Recruiting NCT NCT03770936

Effect of Some Drugs on Liver Fibrosis

Not yet reported Sherief Abd-Elsalam 45 participants Est. completion 2027-11 1 site

Other conditions: Liver Fibroses
View official trial listing →
Recruiting NCT NCT04662723

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

Not yet reported Fondazione Schena 878 participants Est. completion 2028-12-31 2 sites Stand-alone

Other conditions: Glomerulonephritis, Immunoglobulin A Nephropathy
View official trial listing →
Recruiting NCT NCT04962711

Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)

Not yet reported Baker Heart and Diabetes Institute 685 participants Est. completion 2025-12-31 1 site Stand-alone

Heart failure
View official trial listing →
Recruiting NCT NCT04983823

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

Not yet reported Baker Heart and Diabetes Institute 820 participants Est. completion 2025-12-30 1 site Stand-alone

Heart failure
View official trial listing →
Recruiting NCT NCT05030818

Cross-over Study of Coronary Risk Factors With a Polypill

Not yet reported Fundación EPIC 88 participants Est. completion 2026-04-30 1 site Stand-alone

Cardiovascular disease
View official trial listing →
Recruiting NCT NCT05498675

Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site

Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
View official trial listing →
Recruiting NCT NCT05508035

The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection Fraction

Not yet reported John Paul II Hospital, Krakow 488 participants Est. completion 2028-12 1 site Stand-alone

Heart failure
View official trial listing →
Recruiting NCT NCT05942027

Role of Coenzyme Q10 in Chronic Kidney Disease

Not yet reported Tanta University 44 participants Est. completion 2026-07-15 1 site

Chronic kidney disease
View official trial listing →
Recruiting NCT NCT05942053

Role of Vitamin K2 in Chronic Kidney Disease

Not yet reported Tanta University 44 participants Est. completion 2026-07-15 1 site

Chronic kidney disease
View official trial listing →
Recruiting NCT NCT05963568

Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)

Not yet reported Northern California Institute of Research and Education 1000 participants Est. completion 2029-02-01 4 sites Stand-alone

Cardiovascular disease Other conditions: Medication Adherence
View official trial listing →
Recruiting NCT NCT06562582

STunning in Acute Myocardial Infarction - BAS

Not yet reported Vastra Gotaland Region 120 participants Est. completion 2027-12-31 1 site

Other conditions: Myocardial Infarct
View official trial listing →
Recruiting NCT NCT07099677

Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk

Not yet reported Abant Izzet Baysal University 186 participants Est. completion 2026-06-30 1 site Stand-alone

Other conditions: Hypertension, Fall Risk, Postural Balance, Fear of Falling
View official trial listing →
Recruiting NCT NCT07259512

Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure

Not yet reported Evi Liliek Wulandari 80 participants Est. completion 2026-01-31 1 site Stand-alone

Chronic kidney diseaseHeart failure
View official trial listing →
Recruiting NCT NCT07513883

The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.

Not yet reported Ziekenhuis Oost-Limburg 100 participants Est. completion 2028-12 1 site Stand-alone

Heart failure
View official trial listing →
Completed NCT NCT00000620

Action to Control Cardiovascular Risk in Diabetes (ACCORD)

Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 10251 participants Est. completion 2012-12 7 sites

Cardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Coronary Disease
View official trial listing →
Completed NCT NCT00005928

Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation

Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 25 participants Est. completion 2002-02 1 site

Other conditions: Atherosclerosis, Coronary Disease, Vasculitis
View official trial listing →
Completed NCT NCT00044265

Treatment of Pediatric Hypertension With Altace Trial

Not yet reported Pfizer 310 participants Est. completion 2004-11 30 sites

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00054938

Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)

Not yet reported Brigham and Women's Hospital 150 participants Est. completion 2005-12 1 site

Other conditions: Systemic Lupus Erythematosus, Lupus
View official trial listing →
Completed NCT NCT00095290

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

Not yet reported Bristol-Myers Squibb 400 participants Est. completion 2005-11 92 sites Stand-alone

Other conditions: Albuminuria
View official trial listing →
Completed NCT NCT00095654

The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial

Not yet reported Gerstein, Hertzel, MD 5000 participants Est. completion 2006-10

PrediabetesCardiovascular disease Other conditions: Glucose Metabolism Disorders
View official trial listing →
Completed NCT NCT00140647

The Study of Atherosclerosis With Ramipril and Rosiglitazone

Not yet reported Gerstein, Hertzel, MD 1200 participants Est. completion 2006-07

PrediabetesCardiovascular disease Other conditions: Atherosclerosis
View official trial listing →
Completed NCT NCT00141778

Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)

Not yet reported, Not yet reported Vanderbilt University 455 participants Est. completion 2010-08 1 site Stand-alone

Other conditions: Atrial Fibrillation
View official trial listing →
Completed NCT NCT00153101

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Not yet reported Boehringer Ingelheim 31546 participants 732 sites

Cardiovascular disease
View official trial listing →
Completed NCT NCT00160160

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

Not yet reported Solvay Pharmaceuticals 440 participants 63 sites

Type 2 diabetes Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00168467

The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease

Not yet reported Baker Heart Research Institute 40 participants 1 site

Other conditions: Peripheral Arterial Disease
View official trial listing →
Terminated NCT NCT00200694

Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.

Not yet reported Nantes University Hospital 18 participants Est. completion 2007-03 1 site

Other conditions: Heavy Proteinuria
View official trial listing →
Terminated NCT NCT00208221

Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes

Not yet reported Institut de Recherches Cliniques de Montreal 50 participants Est. completion 2007-06 1 site

Type 2 diabetes Other conditions: Hypertension, Albuminuria
View official trial listing →
Completed NCT NCT00219063

A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.

Not yet reported Novartis 844 participants Est. completion 2006-03 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00219089

A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.

Not yet reported Novartis 839 participants Est. completion 2005-08 2 sites

Other conditions: Hypertension, Diabetes Mellitus
View official trial listing →
Completed NCT NCT00221845

Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients

Not yet reported Heidelberg University 400 participants Est. completion 2010-01 33 sites Stand-alone

Other conditions: Children, Chronic Renal Failure, Hypertension, Acquired Kidney Disease, Congenital Kidney Disease
View official trial listing →
Completed NCT NCT00240422

Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes

Not yet reported Boehringer Ingelheim 96 participants Est. completion 2004-07 6 sites

Type 2 diabetes Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00268619

FOCUS:Focus On Coronary Unstable Syndromes

Not yet reported Sanofi

Other conditions: Myocardial Ischemia
View official trial listing →
Completed NCT NCT00273533

Ramipril in Rheumatoid Arthritis

Not yet reported, Not yet reported University of Zurich 13 participants Est. completion 2006-07

Other conditions: Arthritis, Rheumatoid
View official trial listing →
Completed NCT NCT00274599

PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN

Not yet reported Boehringer Ingelheim 812 participants 74 sites

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00274612

Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM

Not yet reported Boehringer Ingelheim 801 participants Est. completion 2003-11 62 sites

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00281593

Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension

Not yet reported Boehringer Ingelheim 1354 participants 119 sites

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00292162

Curing Atrial Fibrillation in Heart Failure

Not yet reported NHS Greater Glasgow and Clyde 41 participants Est. completion 2009-07 1 site

Heart failure Other conditions: Atrial Fibrillation
View official trial listing →
Completed NCT NCT00310778

Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker

Not yet reported Assistance Publique - Hôpitaux de Paris 64 participants Est. completion 2007-03 1 site Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT00325806

Ramipril - Hypertension

Not yet reported Sanofi 1008 participants Est. completion 2005-08

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00343551

Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.

Not yet reported Novartis 654 participants 2 sites

Other conditions: Essential Hypertension
View official trial listing →
Completed NCT NCT00355589

Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

Not yet reported Pfizer Est. completion 2007-03 60 sites

Other conditions: Hypertension, Blood Pressure, High
View official trial listing →
Completed NCT NCT00356395

Safety and Effects of Ramipril Combined With Candesartan

Not yet reported Gachon University Gil Medical Center 40 participants Est. completion 2006-03

Other conditions: Hypertension
View official trial listing →
Status unknown NCT NCT00366119

Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension

Not yet reported Pacific Pharmaceuticals 86 participants Est. completion 2007-06 1 site

Other conditions: Essential Hypertension
View official trial listing →
Completed NCT NCT00367939

Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine

Not yet reported Novartis 132 participants Est. completion 2006-07 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00368277

A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly

Not yet reported Novartis Pharmaceuticals 901 participants Est. completion 2008-02 1 site

Other conditions: Hypertension
View official trial listing →
Terminated NCT NCT00389519

A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents

Not yet reported Pfizer 422 participants Est. completion 2007-11 100 sites Stand-alone

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00391846

Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

Not yet reported AstraZeneca 252 participants Est. completion 2009-01 39 sites

Heart failure Other conditions: Ventricular Dysfunction, Left
View official trial listing →
Completed NCT NCT00421863

Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study

Not yet reported Heart Care Foundation 1111 participants Est. completion 2009-01 45 sites

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00437463

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

Not yet reported Sanofi 60 participants Est. completion 2010-09 1 site Stand-alone

Other conditions: Glomerulonephritis
View official trial listing →
Completed NCT NCT00443794

The Indian POLYCAP Study (TIPS)

Not yet reported St. John's Research Institute 2050 participants Est. completion 2008-10 54 sites

Cardiovascular disease
View official trial listing →
Completed NCT NCT00473174

Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension

Not yet reported University of Vigo 120 participants Est. completion 2008-12 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00480805

HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

Not yet reported Organon and Co 312 participants Est. completion 2002-10-16

Type 2 diabetes Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00489229

To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients

Not yet reported Universiti Sains Malaysia 66 participants Est. completion 2005-12 1 site

Prediabetes Other conditions: Diabetes
View official trial listing →
Completed NCT NCT00502242

Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus

Not yet reported Pfizer 229 participants Est. completion 2013-09 49 sites

Other conditions: Kidney Transplant
View official trial listing →
Completed NCT NCT00507845

Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina

Not yet reported Sanofi 271 participants 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00512759

Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study

Not yet reported University Hospital, Basel, Switzerland 781 participants Est. completion 2019-02-21 12 sites

Heart failure
View official trial listing →
Status unknown NCT NCT00517322

Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan

Not yet reported Università degli Studi dell'Insubria 80 participants Est. completion 2010-08 1 site Stand-alone

Other conditions: Left Atrial Volume, Hypertensive Heart Disease, Antihypertensive Drugs, Diastolic Function, Renin Angiotensin System
View official trial listing →
Completed NCT NCT00529451

Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg

Not yet reported Novartis 1613 participants Est. completion 2008-07 3 sites

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00535925

Nephropathy In Type 2 Diabetes and Cardio-renal Events

Not yet reported University of Campania Luigi Vanvitelli 850 participants Est. completion 2019-05 1 site Stand-alone

Chronic kidney disease
View official trial listing →
Terminated NCT NCT00542269

Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome

Not yet reported Novartis 178 participants Est. completion 2009-07 1 site Stand-alone

Metabolic syndrome
View official trial listing →
Terminated NCT NCT00574834

Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes

Not yet reported University of Maryland, Baltimore 17 participants Est. completion 2014-08 1 site

Metabolic syndrome
View official trial listing →
Completed NCT NCT00582777

African American Study of Kidney Disease and Hypertension ABPM Pilot Study

Not yet reported, Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 180 participants Est. completion 2008-12 16 sites Stand-alone

Other conditions: Hypertensive Renal Disease
View official trial listing →
Completed NCT NCT00607672

The RAS, Fibrinolysis and Cardiopulmonary Bypass

Not yet reported Vanderbilt University 111 participants Est. completion 2011-12 2 sites

Cardiovascular disease Other conditions: Angiotensin Converting Enzyme, Angiotensin Receptor Blockers, Cardiopulmonary Bypass, Fibrinolysis, Inflammation
View official trial listing →
Terminated NCT NCT00608465

Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity

Not yet reported Vanderbilt University 4 participants Est. completion 2011-05 1 site

Metabolic syndrome
View official trial listing →
Completed NCT NCT00631917

A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension

Not yet reported Novartis 774 participants Est. completion 2009-09 7 sites Stand-alone

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00657865

Gene Expression Profiling in Skeletal Muscle of Healthy Subjects Treated With Ramipril

Not yet reported Medical University of Vienna 18 participants Est. completion 2011-08 1 site

Other conditions: Healthy
View official trial listing →
Completed NCT NCT00674596

The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria

Not yet reported Gulhane School of Medicine 60 participants Est. completion 2008-03 1 site

Other conditions: Diabetes, Proteinuria, Renin Angiotensin System
View official trial listing →
Completed NCT NCT00679653

Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives

Not yet reported Abbott 171 participants

Other conditions: Obesity, Hypertension
View official trial listing →
Completed NCT NCT00681226

Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

Not yet reported Bayside Health 200 participants Est. completion 2012-01 1 site

Other conditions: Peripheral Arterial Disease
View official trial listing →
Completed NCT NCT00684489

Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00702091

Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions

Not yet reported Roxane Laboratories 39 participants Est. completion 2005-01 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00702260

Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions

Not yet reported Roxane Laboratories 39 participants Est. completion 2005-01 1 site

Other conditions: Hypertension
View official trial listing →
Status unknown NCT NCT00702936

Telmisartan Versus Ramipril After Acute Coronary Syndrome

Not yet reported Catholic University of the Sacred Heart 50 participants Est. completion 2008-11 1 site

Cardiovascular disease Other conditions: Acute Coronary Syndrome, Coronary Disease
View official trial listing →
Terminated NCT NCT00729365

PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)

Not yet reported Northwestern University 65 participants Est. completion 2010-06 6 sites

Other conditions: Type 1 Diabetes
View official trial listing →
Completed NCT NCT00732069

Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis

Not yet reported Vanderbilt University 19 participants Est. completion 2011-12 1 site

Other conditions: End Stage Renal Failure on Dialysis, Complication of Hemodialysis
View official trial listing →
Terminated NCT NCT00736294

Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter

Not yet reported Centre Hospitalier Universitaire de Saint Etienne 198 participants Est. completion 2015-03 8 sites Stand-alone

Other conditions: Atrial Fibrillation, Atrial Flutter
View official trial listing →
Completed NCT NCT00738660

Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy

Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 30 participants Est. completion 2008-05 1 site Stand-alone

Chronic kidney disease
View official trial listing →
Completed NCT NCT00741585

Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

Not yet reported University of Vigo 21983 participants Est. completion 2018-06-30 20 sites

Cardiovascular diseaseChronic kidney disease Other conditions: Essential Hypertension
View official trial listing →
Completed NCT NCT00750308

Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i

Not yet reported Vanderbilt University 27 participants Est. completion 2009-05

Metabolic syndrome
View official trial listing →
Completed NCT NCT00760214

Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension

Not yet reported Takeda 885 participants Est. completion 2009-04 72 sites

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00770497

Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.

Not yet reported Takeda 172 participants Est. completion 2008-05 13 sites Stand-alone

Other conditions: Inflammation, Hypertension
View official trial listing →
Completed NCT NCT00772577

Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension

Not yet reported Novartis 386 participants Est. completion 2009-03 6 sites

Other conditions: Hypertension
View official trial listing →
Status unknown NCT NCT00819845

Ramipril Versus Carvedilol in Duchenne and Becker Patients

Not yet reported Catholic University, Italy 194 participants Est. completion 2016-12 1 site Stand-alone

Other conditions: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy
View official trial listing →
Completed NCT NCT00828321

Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions

Not yet reported Teva Pharmaceuticals USA 40 participants Est. completion 2004-10 2 sites Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT00829452

Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions

Not yet reported Teva Pharmaceuticals USA 40 participants Est. completion 2004-10 2 sites Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT00829530

Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions

Not yet reported Teva Pharmaceuticals USA 40 participants Est. completion 2004-10 2 sites Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT00841880

China Medical University Hospital (CMUH) Triapin Listing

Not yet reported Sanofi 49 participants Est. completion 2009-09 1 site Stand-alone

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00863915

A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce

Not yet reported Actavis Inc. 40 participants Est. completion 2004-10 1 site

Other conditions: Healthy
View official trial listing →
Completed NCT NCT00864162

A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions

Not yet reported Actavis Inc. 40 participants Est. completion 2004-10 1 site

Other conditions: Healthy
View official trial listing →
Completed NCT NCT00864448

A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions

Not yet reported Actavis Inc. 40 participants Est. completion 2004-10 1 site

Other conditions: Healthy
View official trial listing →
Terminated NCT NCT00878969

Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3

Not yet reported Vanderbilt University 78 participants Est. completion 2015-06 1 site

Other conditions: Oxidative Stress, Endothelial Dysfunction
View official trial listing →
Completed NCT NCT00879476

Bioequivalence Study of Ramipril 10 mg Capsules Under Fasting Conditions

Not yet reported Ranbaxy Laboratories Limited 68 participants Est. completion 2007-03 1 site Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT00879788

Bioequivalence Study of Ramipril 10 mg Capsules Under Fed Conditions

Not yet reported Ranbaxy Laboratories Limited 32 participants Est. completion 2007-03 1 site Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT00893425

Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria

Not yet reported Gulhane School of Medicine 78 participants Est. completion 2009-04 1 site

Chronic kidney disease Other conditions: Proteinuria
View official trial listing →
Completed NCT NCT00905528

TRENDY Follow-up: Study on Endothelial Function in Subjects With Type 2 Diabetes Mellitus

University of Erlangen-Nürnberg Medical School 69 participants Est. completion 2004-12 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT00923156

Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure

Not yet reported Novartis Pharmaceuticals 123 participants Est. completion 2011-02 16 sites Stand-alone

Heart failure
View official trial listing →
Completed NCT NCT00933231

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Not yet reported Astellas Pharma Inc 281 participants Est. completion 2018-04-03 13 sites Stand-alone

Other conditions: Kidney Transplantation
View official trial listing →
Completed NCT NCT00939588

Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients

Not yet reported Novartis Pharmaceuticals 88 participants 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00946465

To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions

Not yet reported Sandoz 48 participants Est. completion 2004-11 Stand-alone

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00946621

To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions

Not yet reported Sandoz 48 participants Est. completion 2004-11 Stand-alone

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00980785

Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's

Not yet reported University of Wisconsin, Madison 14 participants Est. completion 2011-07-26 1 site Stand-alone

Other conditions: Alzheimer's Disease, Hypertension
View official trial listing →
Completed NCT NCT00985322

Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis

Not yet reported Mario Negri Institute for Pharmacological Research 269 participants Est. completion 2016-04 29 sites Stand-alone

Other conditions: Left Ventricular Hypertrophy, Hypertension
View official trial listing →
Terminated NCT NCT01004705

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

Not yet reported Ferrer Internacional S.A. 36 participants Est. completion 2011-03 1 site Stand-alone

Other conditions: Elevated LDL Cholesterol
View official trial listing →
Terminated NCT NCT01005290

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure

Not yet reported Ferrer Internacional S.A. 38 participants Est. completion 2010-10 1 site Stand-alone

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT01037530

Clinical and Cost Effectiveness of ACE Inhibitor, Ramipril, in Intermittent Claudicants

Not yet reported Hull University Teaching Hospitals NHS Trust 33 participants Est. completion 2012-12 1 site Stand-alone

Alcohol use disorder
View official trial listing →
Status unknown NCT NCT01038895

Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria

Not yet reported University of Pavia 120 participants Est. completion 2011-06 1 site

Type 2 diabetes Other conditions: Hypertension
View official trial listing →
Completed NCT NCT01042392

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients

Not yet reported Novartis 506 participants Est. completion 2011-01 98 sites Stand-alone

Other conditions: Essential Hypertension
View official trial listing →
Completed NCT NCT01052272

Impact of Diabetes on Left Ventricular Remodeling

Not yet reported, Not yet reported University of Alabama at Birmingham 72 participants Est. completion 2010-11 1 site

Other conditions: Diabetes
View official trial listing →
Completed NCT NCT01053910

Ramipril 10 mg/Day Prevention

Not yet reported Sanofi 1012 participants 1 site Stand-alone

Other conditions: Atherosclerosis
View official trial listing →
Completed NCT NCT01078363

Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy

Not yet reported Stanford University 96 participants Est. completion 2015-04 2 sites

Other conditions: Cardiac Allograft Vasculopathy
View official trial listing →
Completed NCT NCT01115426

Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis

Not yet reported University Magna Graecia 20 participants Est. completion 2008-01 1 site

Other conditions: IGA Glomerulonephritis
View official trial listing →
Completed NCT NCT01164761

Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions

Not yet reported Dr. Reddy's Laboratories Limited 54 participants Est. completion 2005-10 1 site Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT01164774

Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions

Not yet reported Dr. Reddy's Laboratories Limited 54 participants Est. completion 2005-11 1 site Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT01180413

Intensive Vasodilator Therapy in Patients With Essential Hypertension

Not yet reported Aarhus University Hospital 48 participants Est. completion 2012-04 1 site Stand-alone

Other conditions: Essential Hypertension, High Blood Pressure
View official trial listing →
Completed NCT NCT01195818

Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients

Not yet reported Assistance Publique - Hôpitaux de Paris 53 participants Est. completion 2014-09 1 site Stand-alone

Other conditions: Sickle Cell Disease
View official trial listing →
Completed NCT NCT01225445

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial

Not yet reported Chinese University of Hong Kong 60 participants Est. completion 2010-10 1 site Stand-alone

Other conditions: Biopsy-confirmed IgA Nephropathy, Proteinuria Less Than 0.5 g Per Day, Normal Blood Pressure, Serum Creatinine Below 120 Umol/l
View official trial listing →
Status unknown NCT NCT01230034

Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria

Not yet reported University of Pavia 206 participants Est. completion 2011-07 1 site

Type 2 diabetes Other conditions: Hypertension, Microalbuminuria
View official trial listing →
Terminated NCT NCT01234922

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

Not yet reported Wake Forest University Health Sciences 6 participants Est. completion 2014-04 1 site Stand-alone

Other conditions: Hypertension, Unspecified Adult Solid Tumor, Protocol Specific
View official trial listing →
Completed NCT NCT01284621

Relative Bioavailability of Empagliflozin (BI 10773) and Ramipril Administered Together Compared to Empagliflozin (BI 10773) and Ramipril Alone in Healthy Volunteers

Not yet reported Boehringer Ingelheim 23 participants 1 site

Other conditions: Healthy
View official trial listing →
Terminated NCT NCT01302899

To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy

Not yet reported Novartis Pharmaceuticals 8 participants Est. completion 2011-12 2 sites Stand-alone

Chronic kidney disease
View official trial listing →
Completed NCT NCT01321255

Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.

Not yet reported Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III 2118 participants Est. completion 2014-06 69 sites Stand-alone

Cardiovascular disease
View official trial listing →
Terminated NCT NCT01362218

Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol

Not yet reported Ferrer Internacional S.A. 107 participants Est. completion 2012-04 1 site Stand-alone

Other conditions: Elevated LDL Cholesterol
View official trial listing →
Completed NCT NCT01402479

An Open-labeled Trial of Ramipril in Patients With Migraine

Not yet reported Seoul National University Hospital 50 participants Est. completion 2005-07 1 site

Other conditions: Migraine With Hypertension
View official trial listing →
Withdrawn NCT NCT01432106

The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome

Not yet reported University of Michigan Est. completion 2012-12 1 site

Metabolic syndrome Other conditions: Hypertension
View official trial listing →
Completed NCT NCT01437371

Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?

Not yet reported University Hospital, Clermont-Ferrand 35 participants Est. completion 2014-06 1 site

Heart failure
View official trial listing →
Completed NCT NCT01485978

Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome

Not yet reported Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 66 participants Est. completion 2019-03 1 site

Other conditions: Renal Insufficiency, Chronic
View official trial listing →
Status unknown NCT NCT01500590

Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria

Not yet reported Hospital Authority, Hong Kong 1400 participants Est. completion 2019-08 1 site Stand-alone

Other conditions: Diabetes, Hypertensive Disease
View official trial listing →
Completed NCT NCT01504828

Cardiac Energetics and Function in Normal Human Ageing

Not yet reported Newcastle-upon-Tyne Hospitals NHS Trust 135 participants Est. completion 2015-12 1 site Stand-alone

Other conditions: Left Ventricular Function Systolic Dysfunction, Left Ventricular Function Diastolic Dysfunction, Ageing
View official trial listing →
Completed NCT NCT01646437

The International Polycap Study 3 (TIPS-3)

Not yet reported Population Health Research Institute 7793 participants Est. completion 2021-08-30 9 sites Stand-alone

Cardiovascular disease Other conditions: Fractures, Cancers
View official trial listing →
Completed NCT NCT01669434

Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

Not yet reported University of Nebraska 291 participants Est. completion 2016-12-01 1 site

Other conditions: Hypotension on Induction
View official trial listing →
Completed NCT NCT01686230

Acupuncture in Patients With Stable Angina Pectoris

Not yet reported Chengdu University of Traditional Chinese Medicine 404 participants Est. completion 2017-07 1 site Stand-alone

Other conditions: Angina, Stable
View official trial listing →
Completed NCT NCT01703234

FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients

Not yet reported Gulhane School of Medicine 78 participants Est. completion 2009-04 1 site Stand-alone

Chronic kidney disease Other conditions: Proteinuria
View official trial listing →
Status unknown NCT NCT01715584

Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site

Other conditions: Hypertension
View official trial listing →
Status unknown NCT NCT01743014

Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy

Not yet reported AHEPA University Hospital 60 participants Est. completion 2015-07 2 sites

Chronic kidney disease Other conditions: Diabetes Type 2, Vascular Disease
View official trial listing →
Status unknown NCT NCT01829880

Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure

The University Clinic of Pulmonary and Allergic Diseases Golnik 60 participants Est. completion 2013-08 1 site

Heart failure Other conditions: Cachexia
View official trial listing →
Terminated NCT NCT01856361

Ramipril for the Treatment of Oligospermia

Not yet reported Weill Medical College of Cornell University 2 participants Est. completion 2016-06 1 site Stand-alone

Other conditions: Oligospermia, Teratospermia, Asthenozoospermia, Male Infertility
View official trial listing →
Terminated NCT NCT01867047

ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients

Not yet reported Duke University 59 participants Est. completion 2016-06-24 1 site Stand-alone

Other conditions: Adverse Effects of Angiotensin-converting-enzyme Inhibitors, Hypotension
View official trial listing →
Withdrawn NCT NCT01922141

Aliskiren Study of Safety and Efficacy in Senior Hypertensives

Not yet reported Novartis Pharmaceuticals Est. completion 2018-06

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT01968759

Sevelamer in Proteinuric CKD

Not yet reported Mario Negri Institute for Pharmacological Research 53 participants Est. completion 2015-10 2 sites Stand-alone

Chronic kidney disease
View official trial listing →
Terminated NCT NCT02008786

Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD

Not yet reported Cardiology Research UBC 18 participants Est. completion 2019-09-13 1 site Stand-alone

Other conditions: Coronary Artery Dissection, Spontaneous
View official trial listing →
Completed NCT NCT02029118

Acupoint Application in Patients With Stable Angina Pectoris (AASAP)

Not yet reported Chengdu University of Traditional Chinese Medicine 200 participants Est. completion 2015-08 1 site Stand-alone

Other conditions: Stable Angina Pectoris
View official trial listing →
Completed NCT NCT02086019

Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes

Not yet reported Brighton and Sussex University Hospitals NHS Trust 250 participants Est. completion 2019-12-12 1 site

Other conditions: Acute Coronary Syndromes
View official trial listing →
Completed NCT NCT02130687

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

Not yet reported Vanderbilt University 106 participants Est. completion 2020-08 1 site Stand-alone

Type 2 diabetes Other conditions: Hypertension
View official trial listing →
Completed NCT NCT02200822

Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients

Not yet reported Hasselt University 80 participants Est. completion 2019-02 1 site

Heart failure
View official trial listing →
Completed NCT NCT02214966

Influence of Food on the Bioavailability of Telmisartan / Ramipril Fixed Dose Combination in Healthy Male and Female Volunteers

Not yet reported Boehringer Ingelheim 42 participants Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT02214979

Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers

Not yet reported Boehringer Ingelheim 84 participants Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT02214992

Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers

Not yet reported Boehringer Ingelheim 84 participants Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT02215005

Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers

Not yet reported Boehringer Ingelheim 42 participants Stand-alone

Other conditions: Healthy
View official trial listing →
Status unknown NCT NCT02236806

Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab

Not yet reported Azienda Ospedaliero-Universitaria Careggi 262 participants Est. completion 2022-06 1 site Stand-alone

Other conditions: Breast Cancer, Cardiotoxicity
View official trial listing →
Terminated NCT NCT02271178

Multi-cap for Increase Adherence After Acute Myocardial Infarction

Not yet reported Hospital El Cruce 100 participants Est. completion 2016-09 1 site Stand-alone

Cardiovascular disease
View official trial listing →
Completed NCT NCT02499822

REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial

Not yet reported Istituto Auxologico Italiano 168 participants Est. completion 2020-11-01 3 sites Stand-alone

Other conditions: Hypertension, High Blood Pressure Variability
View official trial listing →
Completed NCT NCT02525081

Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction

Not yet reported Bispebjerg Hospital 63 participants Est. completion 2016-07 1 site Stand-alone

Other conditions: Microvascular Angina
View official trial listing →
Completed NCT NCT02570581

MELA Study - Hedonic Study on the Taste of Drugs Crushed in Food: Observational Study Involving 16 Healthy Volunteers

Not yet reported Centre Hospitalier Universitaire de Nice 16 participants Est. completion 2014-07 1 site

Other conditions: Healthy
View official trial listing →
Completed NCT NCT02596126

Secondary Prevention of Cardiovascular Disease in the Elderly Trial

Not yet reported Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III 2499 participants Est. completion 2022-03-31 113 sites Stand-alone

Cardiovascular disease
View official trial listing →
Completed NCT NCT02632747

Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study

Not yet reported Boehringer Ingelheim 31 participants Est. completion 2019-07-02 1 site Stand-alone

Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1, Obesity
View official trial listing →
Status unknown NCT NCT02721342

Remission Clinic in Proteinuric Chronic Nephropathies

Mario Negri Institute for Pharmacological Research 1500 participants Est. completion 2022-11 13 sites

Chronic kidney disease
View official trial listing →
Completed NCT NCT02729441

Perindopril vs Ramipril for Persistence in MAU Reduction Study

Not yet reported Sunnybrook Health Sciences Centre 23 participants Est. completion 2012-12 1 site

Other conditions: Diabetes, Microalbuminuria
View official trial listing →
Status unknown NCT NCT02791958

Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy

Not yet reported Ferrer Internacional S.A. 528 participants Est. completion 2017-10 36 sites Stand-alone

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT02832973

Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension

Not yet reported Sao Jose do Rio Preto Medical School 72 participants Est. completion 2018-03 1 site

Other conditions: Hypertension Resistant to Conventional Therapy
View official trial listing →
Completed NCT NCT02901977

Doxazosin and Ramipril in Hypertension

Not yet reported Karolinska Institutet 71 participants Est. completion 2015-04 1 site Stand-alone

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT02924727

Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI

Not yet reported Novartis Pharmaceuticals 5669 participants Est. completion 2021-02-26 486 sites Stand-alone

Cardiovascular disease
View official trial listing →
Completed NCT NCT03011775

Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease

Not yet reported Ukrainian Medical Stomatological Academy 43 participants Est. completion 2015-09 1 site Stand-alone

Other conditions: Adverse Effect, Atherosclerosis, Coronary, Insulin Resistance Syndrome
View official trial listing →
Completed NCT NCT03099213

An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event

Not yet reported Sanofi 179 participants Est. completion 2010-04-23 1 site Stand-alone

Cardiovascular disease
View official trial listing →
Status unknown NCT NCT03201185

Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI)

Not yet reported Hospital Clínico Universitario de Valladolid 194 participants Est. completion 2023-08 1 site Stand-alone

Other conditions: Transcatheter Aortic Valve Replacemen, Angiotensin-Converting Enzyme Inhibitors
View official trial listing →
Completed NCT NCT03414723

A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril

Not yet reported Sanofi 16 participants Est. completion 2018-03-10 1 site Stand-alone

Other conditions: Diabetes Mellitus, Healthy Subjects
View official trial listing →
Completed NCT NCT03475186

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Not yet reported Wake Forest University Health Sciences 75 participants Est. completion 2025-03-25 423 sites Stand-alone

Other conditions: Glioblastoma, Radiotherapy; Complications, Cognitive Decline, Chemoradiation
View official trial listing →
Completed NCT NCT03715998

Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction

Not yet reported Quantum Genomics SA 295 participants Est. completion 2021-07-08 7 sites

Cardiovascular disease
View official trial listing →
Completed NCT NCT03979976

Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus

Not yet reported, Not yet reported Federal University of São Paulo 37 participants Est. completion 2013-09 1 site

Other conditions: Systemic Lupus Erythematosus
View official trial listing →
Status unknown NCT NCT03991910

The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients

Not yet reported Universitas Indonesia 66 participants Est. completion 2024-08-08 1 site Stand-alone

Other conditions: Rheumatic Heart Disease, Mitral Stenosis, Rheumatic Mitral Stenosis, Fibrosis; Heart, ACE Inhibitor
View official trial listing →
Status unknown NCT NCT04143412

Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination

Not yet reported Beni-Suef University 75 participants Est. completion 2020-03 1 site

Chronic kidney diseaseType 2 diabetes
View official trial listing →
Active, not recruiting NCT NCT04173949

Explorative Study for Treating Persistent Developmental Stuttering With Ramipril

Not yet reported HaEmek Medical Center, Israel 10 participants Est. completion 2025-12-30 2 sites Stand-alone

Other conditions: Persistent Developmental Stuttering
View official trial listing →
Completed NCT NCT04262765

Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin

Not yet reported Midas Pharma GmbH 18 participants Est. completion 2019-03-26 1 site Stand-alone

Other conditions: Healthy Volunteers
View official trial listing →
Completed NCT NCT04320589

the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma

Not yet reported National Cancer Institute, Egypt 30 participants Est. completion 2021-08-30 1 site

Other conditions: Pheochromocytoma
View official trial listing →
Suspended NCT NCT04330300

Coronavirus (COVID-19) ACEi/ARB Investigation

Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site

Other conditions: Hypertension, COVID-19
View official trial listing →
Completed NCT NCT04354350

Replication of the ONTARGET Antihypertensive Trial in Healthcare Claims Data

Brigham and Women's Hospital 63744 participants Est. completion 2021-02-08 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT04364139

African American Study of Kidney Disease and Hypertension

Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1094 participants Est. completion 2007-06-30 Stand-alone

Other conditions: Hypertensive Nephrosclerosis, Chronic Renal Insufficiency
View official trial listing →
Completed NCT NCT04366050

Ramipril for the Treatment of COVID-19

Not yet reported University of California, San Diego 160 participants Est. completion 2021-05-12 1 site Stand-alone

Other conditions: COVID-19
View official trial listing →
Completed NCT NCT04467931

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

University of Utah 22213 participants Est. completion 2020-12-31 1 site

Other conditions: Hypertension, COVID
View official trial listing →
Completed NCT NCT04582097

Ramipril in Pediatric Patients on Hemodialysis

Not yet reported, Not yet reported Ain Shams University 135 participants Est. completion 2020-02-28 1 site Stand-alone

Other conditions: Hemodialysis
View official trial listing →
Completed NCT NCT04591210

The COVID-RASi Trial (COVID-19)

Not yet reported Ottawa Heart Institute Research Corporation 372 participants Est. completion 2024-12-30 31 sites Stand-alone

Cardiovascular disease Other conditions: COVID-19
View official trial listing →
Status unknown NCT NCT04962841

Nutraceuticals and Drug Treatment in Frail Older Adults

University of Campania Luigi Vanvitelli 485 participants Est. completion 2023-04-01 1 site

Other conditions: Frailty
View official trial listing →
Status unknown NCT NCT05122780

Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).

Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120 participants Est. completion 2025-07 3 sites

Cardiovascular disease
View official trial listing →
Not yet recruiting NCT NCT05133050

Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants

Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 510 participants Est. completion 2026-12-31 1 site Stand-alone

Other conditions: Alport Syndrome
View official trial listing →
Status unknown NCT NCT05271448

Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography

Not yet reported An-Najah National University 600 participants Est. completion 2024-08-01 1 site Stand-alone

Chronic kidney disease Other conditions: Contrast-induced Nephropathy, Ischemic Heart Disease
View official trial listing →
Completed NCT NCT05438316

Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditions

Not yet reported Pharmtechnology LLC 50 participants Est. completion 2022-11-17 1 site

Other conditions: Bioequivalence
View official trial listing →
Active, not recruiting NCT NCT05637853

Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction

Not yet reported Göteborg University 60 participants Est. completion 2026-08-26 1 site Stand-alone

Heart failure
View official trial listing →
Completed NCT NCT05685277

Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions

Not yet reported Pharmtechnology LLC 50 participants Est. completion 2023-07-31 1 site

Other conditions: Bioequivalence
View official trial listing →
Completed NCT NCT05849766

Effect of Dapagliflozin on Cardiac Structure, Function and Secondary Mitral Regurgitation in Patients with Left Ventricle Dysfunction

Not yet reported October 6 University 150 participants Est. completion 2024-09-01 1 site

Other conditions: Dilated Cardiomyopathy
View official trial listing →
Completed NCT NCT06104423

Open-label inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients

Not yet reported Menarini International Operations Luxembourg SA 266 participants Est. completion 2024-02-19 1 site

Other conditions: Hypertension
View official trial listing →
Status unknown NCT NCT06187493

Treatment of Patients With Diabetic Kidney Disease

Not yet reported Assiut University 70 participants Est. completion 2025-12-31

Chronic kidney disease
View official trial listing →
Status unknown NCT NCT06304896

Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy

Not yet reported Arab Contractors Medical Centre 150 participants Est. completion 2025-12-01 1 site

Other conditions: Chemotherapy Induced Systolic Dysfunction
View official trial listing →
Status unknown NCT NCT06515678

Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sites

Other conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, Hypertension
View official trial listing →
Completed NCT NCT07023016

Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure

Not yet reported, Not yet reported National Heart Institute, Egypt 515 participants Est. completion 2025-02-28 2 sites

Heart failureChronic kidney disease
View official trial listing →
Not yet recruiting NCT NCT07027774

Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial（HERO -aCKD）

Not yet reported First Affiliated Hospital of Wannan Medical College 429 participants Est. completion 2027-12-30

Chronic kidney disease
View official trial listing →
Completed NCT NCT07045038

Blood Flow Restricted Resistance Exercises Versus Low Level Laser on Cardiac Functions in Patients With Chronic Heart Failure

Not yet reported Cairo University 60 participants Est. completion 2026-04-20 1 site

Heart failure
View official trial listing →
Completed NCT NCT07184918

Effect of Continuing vs. Discontinuing ACE Inhibitors on Renal Function After Coronary Angiography

Not yet reported Tanta University 44 participants Est. completion 2025-06-01 1 site Stand-alone

Other conditions: Contrast-Induced Nephropathy, Coronary Angiography, Acute Kidney Injury
View official trial listing →
Not yet recruiting NCT NCT07262710

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19

Cardiovascular disease
View official trial listing →
Completed NCT NCT07315139

Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients

Not yet reported Ain Shams University 42 participants Est. completion 2023-08-31 1 site

Chronic kidney disease Other conditions: Pentoxifylline, Inflammatory Markers, Non-Diabetic
View official trial listing →
Enrolling by invitation NCT NCT07547878

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site

Chronic kidney diseaseType 2 diabetes
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT07547878

Also known as: Altace, Ramipril

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.